908 Devices Posts $19 Million in Revenue, Beats Third-Quarter Estimates
Key Facts
908 Devices reported third-quarter 2026 results before the market opened on November 10, posting revenue of $19 million, above the analyst average estimate of $18.57 million, according to Investing.com. The per-share loss was $0.11, compared with analysts’ estimate of a $0.16 loss, meaning the reported loss was smaller than expected. The figures reflected a beat on revenue and earnings per share for the quarter. The company had scheduled the results for release before the market opened on Tuesday, November 10, with an investor call at 8:30 a.m. Eastern Time. When the results report was published, Investing.com data showed the shares up 9%, with the previous close noted at $11.51.
The company raised its fiscal 2026 revenue outlook to a range of $68.5 million to $70 million, according to Investing.com, compared with the analyst consensus of $69.12 million. The published average estimate falls within the new range, which runs from $68.5 million at the low end to $70 million at the high end. The company had raised the low end of its forecast earlier in the year, from $67 million to $70 million in May, then to $68 million to $70 million in August. In November, the range became $68.5 million to $70 million. This progression allows the updated guidance to be compared with previous forecasts and the market consensus for the fiscal year, alongside results for the quarter ended.
Third-quarter results follow the figures the company reported for the second quarter of 2026, when revenue was $16.1 million, up 23% year over year. Recurring revenue that quarter was $4.9 million, or 31% of total revenue, according to the company’s statement. These figures provide context for comparing quarterly revenue and income components across the two periods, while the second-quarter figures remain specific to that period. Annual revenue guidance also moved gradually during the year, with the low end rising from $67 million in May to $68 million in August and then $68.5 million in November. The high end remained at $70 million in these updates.
908 Devices manufactures handheld devices for analyzing chemicals at the point of need, and says they are used to screen unknown and unseen substances in health and safety and defense technology applications. These applications put the nature of the company’s business in context when reading its financial results, as it sells field-analysis instruments tied to those uses. The company had announced that third-quarter results would be released before the market opened on November 10, and scheduled the investor call for 8:30 a.m. Eastern Time that day. MASS shares closed at $11.51 on November 9, according to EL7 data. That close preceded the results announcement and therefore does not, by itself, represent a reported market response to the figures or the updated outlook.